BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 20463406)

  • 1. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons.
    Manczak M; Mao P; Calkins MJ; Cornea A; Reddy AP; Murphy MP; Szeto HH; Park B; Reddy PH
    J Alzheimers Dis; 2010; 20 Suppl 2(Suppl 2):S609-31. PubMed ID: 20463406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease.
    Calkins MJ; Manczak M; Mao P; Shirendeb U; Reddy PH
    Hum Mol Genet; 2011 Dec; 20(23):4515-29. PubMed ID: 21873260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria-Division Inhibitor 1 Protects Against Amyloid-β induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer's Disease.
    Reddy PH; Manczak M; Yin X
    J Alzheimers Dis; 2017; 58(1):147-162. PubMed ID: 28409745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease.
    Yin X; Manczak M; Reddy PH
    Hum Mol Genet; 2016 May; 25(9):1739-53. PubMed ID: 26908605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease.
    Reddy PH; Manczak M; Kandimalla R
    Hum Mol Genet; 2017 Apr; 26(8):1483-1496. PubMed ID: 28186562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease.
    McManus MJ; Murphy MP; Franklin JL
    J Neurosci; 2011 Nov; 31(44):15703-15. PubMed ID: 22049413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of neurons treated with herbicides and neuroprotection by mitochondria-targeted antioxidant SS31.
    Reddy TP; Manczak M; Calkins MJ; Mao P; Reddy AP; Shirendeb U; Park B; Reddy PH
    Int J Environ Res Public Health; 2011 Jan; 8(1):203-21. PubMed ID: 21318024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer's Disease.
    Reddy PH; Manczak M; Yin X; Reddy AP
    J Alzheimers Dis; 2018; 62(4):1549-1565. PubMed ID: 29400667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease.
    Ng LF; Gruber J; Cheah IK; Goo CK; Cheong WF; Shui G; Sit KP; Wenk MR; Halliwell B
    Free Radic Biol Med; 2014 Jun; 71():390-401. PubMed ID: 24637264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer's disease.
    Reddy PH; Manczak M; Yin X; Grady MC; Mitchell A; Kandimalla R; Kuruva CS
    J Investig Med; 2016 Dec; 64(8):1220-1234. PubMed ID: 27521081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mitochondria-targeted small molecule SS31 delays progression of behavioral deficits by attenuating β-amyloid plaque formation and mitochondrial/synaptic deterioration in APP/PS1 mice.
    Jia YL; Wang W; Han N; Sun HL; Dong FM; Song YX; Feng RF; Wang JH
    Biochem Biophys Res Commun; 2023 May; 658():36-43. PubMed ID: 37018887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
    Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
    Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.
    Manczak M; Calkins MJ; Reddy PH
    Hum Mol Genet; 2011 Jul; 20(13):2495-509. PubMed ID: 21459773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid attenuates Aβ
    Zhao L; Zhu L; Guo X
    Biomed Pharmacother; 2018 Oct; 106():77-82. PubMed ID: 29957469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of mitophagy and ATP-related metabolomics based on β-amyloid levels in Alzheimer's disease.
    Xiong X; Li S; Han TL; Zhou F; Zhang X; Tian M; Tang L; Li Y
    Exp Cell Res; 2020 Nov; 396(1):112266. PubMed ID: 32905804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy in Disruption of Mitochondrial Dynamics by Aβ (1-42) and Glia Maturation Factor (GMF) in SH-SY5Y Cells Is Mediated Through Alterations in Fission and Fusion Proteins.
    Ahmed ME; Selvakumar GP; Kempuraj D; Thangavel R; Mentor S; Dubova I; Raikwar SP; Zaheer S; Iyer S; Zaheer A
    Mol Neurobiol; 2019 Oct; 56(10):6964-6975. PubMed ID: 30949973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.
    Yao J; Du H; Yan S; Fang F; Wang C; Lue LF; Guo L; Chen D; Stern DM; Gunn Moore FJ; Xi Chen J; Arancio O; Yan SS
    J Neurosci; 2011 Feb; 31(6):2313-20. PubMed ID: 21307267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dactylorhin B reduces toxic effects of beta-amyloid fragment (25-35) on neuron cells and isolated rat brain mitochondria.
    Zhang D; Zhang Y; Liu G; Zhang J
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Nov; 374(2):117-25. PubMed ID: 17021851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased proteolytic activity of the mitochondrial amyloid-β degrading enzyme, PreP peptidasome, in Alzheimer's disease brain mitochondria.
    Alikhani N; Guo L; Yan S; Du H; Pinho CM; Chen JX; Glaser E; Yan SS
    J Alzheimers Dis; 2011; 27(1):75-87. PubMed ID: 21750375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.